These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 759804)
21. Antiplatelet drugs after myocardial infarction. Med Lett Drugs Ther; 1980 Mar; 22(6):25-6. PubMed ID: 7360108 [No Abstract] [Full Text] [Related]
22. Aspirin in the prophylaxis of venous and arterial diseases. Loew D Proc R Soc Med; 1977; 70 Suppl 7(Suppl 7):28-31. PubMed ID: 615313 [No Abstract] [Full Text] [Related]
23. Use of platelet antagonists in the treatment of migraine. Dalessio DJ Headache; 1976 Jul; 16(3):129-30. PubMed ID: 965226 [No Abstract] [Full Text] [Related]
24. [Treatment of transient ischemic attacks (author's transl)]. Regli F; Michaud PA Schweiz Rundsch Med Prax; 1978 Jan; 67(3):86-91. PubMed ID: 619355 [No Abstract] [Full Text] [Related]
25. The prevention of thrombosis. Bove LG J Maine Med Assoc; 1974 Oct; 65(10):233-5. PubMed ID: 4610070 [No Abstract] [Full Text] [Related]
27. [Place of antiplatelet agents in the prevention of cerebral ischemic strokes]. Bousser MG Ann Med Interne (Paris); 1983; 134(2):79-83. PubMed ID: 6349464 [No Abstract] [Full Text] [Related]
28. [Inhibitors of platelet aggregation in the therapy of arteriosclerosis obliterans]. Zabel Langhennig R Z Gesamte Inn Med; 1979 May; 34(10):117-20. PubMed ID: 483916 [TBL] [Abstract][Full Text] [Related]
29. [Thrombocyte-aggregation inhibitors following open or semi-open endarterectomy-preliminary results of a prospective study]. Vasa; 1978; 7(1):82-5. PubMed ID: 636560 [No Abstract] [Full Text] [Related]
30. [Hypercoagulability and cerebral infarction]. Matsuda T No To Shinkei; 1986 Apr; 38(4):317-27. PubMed ID: 3013261 [No Abstract] [Full Text] [Related]
31. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention. Polli EE; Cortellaro M Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788 [No Abstract] [Full Text] [Related]
32. [Role of platelet anti-aggregants in cardiovascular surgery]. Limet R Rev Med Liege; 1987 May; 42(10):493-5. PubMed ID: 3497419 [No Abstract] [Full Text] [Related]
33. [Critical approach to a therapeutic trial in secondary prevention of cerebral ischemic accidents by antiaggregants]. Guiraud-Chaumeil B Presse Med; 1983 Dec; 12(48):3045-8. PubMed ID: 6228912 [No Abstract] [Full Text] [Related]
34. The thrombogenicity of Dacron arterial grafts and its modification by platelet inhibitory drugs. Kester RC Ann R Coll Surg Engl; 1984 Jul; 66(4):241-6. PubMed ID: 6234841 [TBL] [Abstract][Full Text] [Related]
35. [Conservative therapy of peripheral arterial occlusive disease]. Frauchiger B Schweiz Rundsch Med Prax; 1990 Dec; 79(50):1560-3. PubMed ID: 2270377 [TBL] [Abstract][Full Text] [Related]
36. [Current clinical results of antiplatelet medication]. Ordinas A Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391 [No Abstract] [Full Text] [Related]
38. Aspirin and recurrent myocardial infarction. Jones RJ JAMA; 1980 Aug; 244(7):667-8. PubMed ID: 6993715 [No Abstract] [Full Text] [Related]
39. Effect of platelet aggregation inhibitors on the rate of thrombectomy following arterial reconstructions with Gore-Tex prostheses: a retrospective study. Broomé A; Davidsson T; Eklöf B; Hansson L Vasa; 1982; 11(3):210-2. PubMed ID: 7136240 [No Abstract] [Full Text] [Related]